Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries

Authors:

Schwoebel V, Trébucq A, Kashongwe Z, Bakayoko AS, Kuaban C, Noeske J, Harouna SH, Souleymane MB, Piubello A, Ciza F, Fikouma V, Gasana M, Ouedraogo M, Gninafon M, Van Deun A, Tagliani E, Cirillo DM, Koura KG, Rieder HL

Review: EclinicalMedicine

Date: 2020

Pagination:  20:100268